Related Experiment Video
Updated: Jan 1, 2026
08:12
Fully Endoscopic Mitral Valve Repair with Percutaneous Cannulation of Groin Vessels
Published on: May 26, 2023
2.1K
Multivalvular Disease: Percutaneous Management in 2019 and Beyond
Magdalena Erlebach1,2, Rüdiger Lange1,2
1Department of Cardiovascular Surgery, German Heart Centre Munich, Germany.
Interventional Cardiology (London, England)
|December 24, 2019
Summary
Multivalvular disease (MVD) presents complex challenges due to multiple valve defects. This article explores percutaneous treatment options for these challenging MVD cases.
Area of Science:
- Cardiology
- Interventional Cardiology
- Cardiac Surgery
Background:
- Multivalvular disease (MVD) is prevalent and characterized by diverse, interacting valve pathologies.
- Current clinical trials and guidelines predominantly address single-valve disease, lacking specific recommendations for MVD.
- The complexity of MVD necessitates tailored treatment strategies beyond single-valve disease management.
Purpose of the Study:
- To provide an overview of percutaneous treatment possibilities for patients with multivalvular disease.
- To address the unmet need for evidence-based recommendations in MVD management.
- To highlight interventional approaches for complex cardiac valve conditions.
Main Methods:
- Review of current literature on percutaneous interventions for valvular heart disease.
- Analysis of case studies and procedural outcomes in MVD patients.
- Synthesis of expert opinions and emerging techniques in interventional cardiology for MVD.
Main Results:
- Percutaneous options are emerging as viable alternatives for select MVD patients.
- Interactions between diseased valves can influence procedural choice and outcomes.
- Successful percutaneous treatment requires careful patient selection and procedural planning.
Conclusions:
- Percutaneous interventions offer promising therapeutic avenues for multivalvular disease.
- Further research is needed to establish standardized guidelines for MVD percutaneous treatment.
- Individualized treatment strategies are crucial for optimizing outcomes in MVD patients.
Related Concept Videos
01:25Mitral Regurgitation III: Medical Management
224
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
224
01:26Mitral Stenosis III: Medical Management
198
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
198
01:25Aortic Regurgitation III: Medical Management
326
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
326
01:22Mitral Valve Prolapse II: Assessment and Management
319
IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
319
01:21Rheumatic Heart Disease III: Medical Management
242
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
242
01:29Cardiomyopathy V: Interprofessional Care
274
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
274